A rapidly growing biotechnology company that is pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology. Our partner is committed to developing a differentiated class of therapeutics for oncology indications and more.
This influential hire led the clinical pharmacology function at one of the most exciting and scientifically intriguing biotechnology companies in the area. This hire was a key member of multidisciplinary drug development project teams and provided subject matter expertise in quantitative pharmacology. This role sat within a growing clinical department in the early oncology space involving several highly novel peptide therapeutics.
days until hired candidate presented
days until search completed